FDA NDC Directory · JSON-LD · Markdown

SUCCINYLCHOLINE CHLORIDE

NDC 43066-129 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerBaxter Healthcare Corporation
Marketing categoryAbbreviated NDA (generic) · App ANDA218878
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsSUCCINYLCHOLINE CHLORIDE DIHYDRATE (20 mg/mL)
Marketing started20240924
Package count1

External sources

Source: openFDA. Public-domain (CC0).